Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older

Table 1 Characteristics and clinical background of the study population

No.	Sex	Age	T	Longest diameter	Short diameter	Thickness	Tumor type	External RT dose	Brachytherapy dose	Radioactive Source	Initial response	Survival	Disease control	Outcome	Complications	Comorbidity
		(year)		(mm)	(mm)	(mm)		(Gy)	(Gy)			(year)		(status)
1	F	86	2	25	15	5	exo		73	Ir	CR	1.2	NED	DID
2	F	85	2	25	13	5	sup	30	60	Ra	CR	7	NED	DID
3	M	82	1	20	11	5	sup		70	Ra	CR	2	NED	DID (senile decay)
4	F	82	1	20	7	3	exo+ulc		65	Ir	CR	6	NED	DID (senile decay)		Hypertention
5	M	82	2	35	23	15	ins+ulc	30	60	Ir	CR	3	NED	DID
6	M	82	2	25	12	10	NA		68	Ir	CR	1	NED	Alive		TIA
7	F	81	2	25	12	10	ulc		76	Ir	CR	14	nodal failure 4M	Alive (salvaged by surgery)
8	F	82	2	38	17	10	ind		48	ms	CR	2.5	NED	Alive	Ulcer and bone exposure after biopsy
9	M	81	2	24	15	12	ind		60	Ir	CR	1.4	nodal failure 8M	Dead (nodal failure)
10	F	80	2	23	7	5	ind		70	Ir	CR	12	NED	DID (senile decay)		Hypertention
11	M	80	2	23	18	7	exo		75	Ir	CR	6	NED	Alive		Hypertention
12	M	80	2	NA	NA	NA	NA		70	Ir	CR	2	NED	DID
13	M	80	3	42	25	25	ulc	33	60	ms	CR	1.4	NED	DID
14	M	80	3	42	23	13	ulc+ind	30	85	Ra	CR	3	NED	DID (senile decay)
15	F	83	3	42	20	20	ulc+ind	30	70	Ra	PR	1	nodal failure 0M	Dead (nodal failure and local failure)
16	F	89	3	50	30	20	ulc+ind	36	32	ms	CR	1.3	NED	DID
17	F	83	2	31	24	8	ind+exo		70	Ir	CR	4	NED	DID
18	M	81	3	35	28	15	ulc+ind	36	54	Ir	CR	0.9	NED	DID
19	F	80	2	25	20	10	ind		70	Au	PR	1.8	local failure 4M	Dead (local failure)
20	F	80	2	25	20	6	ind	50	54	Ir	CR	2	NED	Alive
21	F	82	2	27	22	12	exo		54	ms	CR	2	NED	Alive	Mild ulcer, pain

Ir; Ir-192, Ra; Ra-226, ms; Ir-192 microSelectron-HDR, Au; Au-198 grain
sup; superficial type, exo;exophytic type, ind; indurative type, ulc; ulcerative type
DID; died for intercurrent disease, DT; death for tongue cancer, NED; no evidence of disease, NA; not avairalble
TIA; transient ischemic attack

ISSN: 1748-717X